LY 2928057

Drug Profile

LY 2928057

Alternative Names: Anti-ferroportin antibody; LY-2928057

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Eli Lilly
  • Class Antianaemics; Antibodies; Monoclonal antibodies
  • Mechanism of Action Cation transport protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Anaemia

Most Recent Events

  • 03 Dec 2016 Adverse event, pharmacodynamics and pharmacokinetics data from a clinical trial in Anaemia presented at the 58th Annual Meeting and Exposition of the American Society of Hematology (ASH-Hem-2016)
  • 21 Apr 2014 Phase-II clinical trials in Anaemia in USA (IV)
  • 01 Dec 2013 Phase-I clinical trials in Anaemia in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top